Connect with us

International

Migrants often can’t access US health care until they are critically ill – here are some of the barriers they face

More than 11 million migrants who lack papers live in the United States, and many of them are ineligible for health coverage.

Published

on

'We heal alone,' a migrant to the U.S. told a researcher. Jasmin Merdan/Moment via Getty Images

“Can you tell me about cancer care for the undocumented?” I asked Henry during an interview. He was a doctor who volunteered his time at a community-based clinic designed exclusively for low-income undocumented migrants.

I use pseudonyms throughout this story to protect migrants’ identities.

“It’s bad,” Henry said. “Cancer care for the undocumented is not there. It’s just not there for the most part. They’re dying of cancer. Period.”

“So where do they go?” I asked.

“They don’t,” he responded solemnly. “They either go back to their home countries or they just live with it until they die. That’s what happens.”

As a medical sociologist and expert in health care disparities between noncitizens and citizens, my research explores the many ways that health care and immigration collide.

Though most migrants have some form of legal documents like passports, visas and identity cards, I use the term “undocumented” in this article to refer to those whose documents are expired, invalid or otherwise missing. I feel the term is useful because it captures a heightened sense of insecurity and instability that many migrants face in their daily lives.

According to Migration Policy Institute estimates, more than 11 million undocumented migrants are living in the United States, and many of them are ineligible for health coverage. Though some states are working to challenge this, undocumented migrants remain one of the largest uninsured populations in the country.

For low-income undocumented migrants, navigating the U.S. health care system involves a number of risks, challenges and consequences that often make them sicker. My research is designed to shed light on these experiences.

Chilling effects: Self-denied care

In their 2020 article in the “Journal of Health and Social Behavior,” sociologists Andrea Gómez Cervantes and Cecilia Menjívar shared the story of a 30-year-old undocumented Mexican woman they called Amelia, who was apprehensive about taking her husband to the hospital for care. During an interview with the researchers, Amelia said she was afraid the hospital would check their immigration status.

“We decided that when we get sick, it’s better if we don’t go [to the hospital],” Amelia told the researchers. “We heal alone, we heal ourselves at home, or we would go to the Mexican store asking about medicines that we knew from Mexico or here in the stores.”

Restrictive immigration policy and a fervent anti-immigrant environment creates what immigration scholars call “chilling effects” for undocumented migrants. It makes safe spaces like hospitals and clinics feel unsafe. Fearing that health practitioners will out them for their legal status, many migrants decide to forego seeking care altogether.

According to the National Immigration Law Center, most health care providers are not obligated to ask about their patients’ legal status. Legally, the institutions of health care and immigration are supposed to operate separately, but this could change.

A Latino teen hoists a harvesting bucket market with the words
A 16-year-old protests against Florida Senate bill 1718 in Immokalee, Fla., an area known for its tomato-growing. Rebecca Blackwell/AP

For example, in early May 2023, Florida Gov. Ron DeSantis signed Senate Bill 1718, which, among other things, requires hospitals to ask their patients about their immigration status.. Though migrants will have the option to “decline to answer,” questions about legal status will likely be enough to deter many from seeking care. It’s still yet to be determined whether other states will follow suit.

Why IDs matter: Waiting for care

Adrian, an undocumented Mexican man, needed to see a doctor to have his hernia surgery scheduled. He handed his ID – a consular identification card issued by the Mexican government - and insurance card to the check-in staff member, who responded with a smile and gestured toward the waiting area: “They’ll call you in shortly.”

Adrian’s surgery was scheduled later that afternoon.

That same day, Rodney, an undocumented Honduran man, arrived at a different clinic, also in need of a hernia surgery. However, two things distinguished Rodney from Adrian. The first was that Rodney’s pain was far more intense. Small movements caused Rodney severe pain in his abdomen, and if he pushed himself too far, his intestines could become strangulated, leading to a cutoff in blood flow and death. The second distinction was that Rodney had no ID.

“I’m sorry,” the staff member said. “Without an ID, I can’t check you in.”

Disheartened, Rodney left the clinic with a hand pressed to his stomach. The pain continued, and the waiting game began.

Like other low-income undocumented migrants without an ID, Rodney was unable to legally access a primary care provider and obtain a referral to surgically fix his hernia. This meant that Rodney had no other choice than to wait for his hernia to turn into a life-threatening situation, at which point he would be eligible for emergency care under the 1986 Emergency Medical Treatment and Active Labor Act.

Rodney’s case was one of many that emerged in my study about how low-income undocumented migrants navigate today’s health care system. Checking for IDs is a routine practice in medical settings. For health practitioners, IDs are necessary for medical reimbursement claims.

When undocumented migrants cannot provide an ID, they are often denied care and begin a trajectory of exacerbated suffering. For some, this means having their long-term care needs relegated to private, medically unaccredited personal care homes. For others, this means an involuntary waiting game where, for many, death seems like the only possible way out.

Under the current system, emergency care becomes possible for low-income undocumented migrants without an ID only after their bodies fail. For Rodney, care was only possible if he let his hernia worsen. In another case in my study, Pedro, an undocumented Mexican man with a urinary tract abnormality, had to wait for his kidneys to completely shut down before he could seek emergency room services.

“I’m just tired,” Pedro told me. “Waiting all the time. And now, I’m waiting to die.”

Health practitioners vow to “do no harm,” but when it comes to immigrant health care, the system is set up in way that legally inhibits them from “doing good.”

A medic, dressed in blue garb and wearing a mask, takes a patient's blood pressure.
A medic from Houston EMS takes the blood pressure of a Mexican immigrant with possible COVID-19 symptoms. John Moore via Getty Images

Medical deportation: Repatriated by hospitals

Legal scholar Lori Nessel opened her article in the Indiana Journal of Global Legal Studies with the story of a 20-year-old undocumented Mexican migrant construction worker she called Quelino. After accidentally falling over 20 feet to the ground, Quelino became comatose for three days and woke up with severe spinal injuries. The hospital treated Quelino for a few months but could not seek reimbursement for ongoing care because of his legal status.

Just before Christmas, and without obtaining Quelino’s consent or notifying the Mexican Consulate, the hospital put Quelino on a private plane to a Mexican hospital that was ill-equipped to care for him. After a year of suffering in this hospital, Quelino died.

Quelino experienced what immigration scholars call “medical deportation.” Also referred to as “medical repatriation,” medical deportation refers to the practice of forcibly removing low-income, uninsured, undocumented patients to other countries, often without their consent.

While the term “deportation” might suggest involvement from U.S. Immigration and Customs Enforcement, border patrol officials are not involved in medical deportation. Hospitals facilitate medical deportation without any government oversight.

The 1986 Emergency Medical Treatment and Active Labor Act requires hospitals to treat everyone – citizens and noncitizens – in emergency cases. After patients are stabilized, the law also requires hospitals to transfer or discharge patients to “appropriate” medical facilities. Hospitals want to accomplish this quickly because they are not reimbursed for post-emergency care. Ongoing care is expensive, and undocumented migrants’ ineligibility for health coverage makes it nearly impossible for migrants to cover costs.

Consequently, hospitals – recognizing that it is cheaper to transfer low-income undocumented migrants to another country than to continue caring for them in their own facilities – sign off on medical deportations to save money. This happens to hundreds, if not thousands, of migrants, according to sociologist Lisa Sun-Hee Park of the University of California, Santa Barbara.

This is what immigrant health care looks like today.

Anthony Jimenez received funding from the Ford Foundation.

Read More

Continue Reading

International

Analyst reviews Apple stock price target amid challenges

Here’s what could happen to Apple shares next.

Published

on

They said it was bound to happen.

It was Jan. 11, 2024 when software giant Microsoft  (MSFT)  briefly passed Apple  (AAPL)  as the most valuable company in the world.

Microsoft's stock closed 0.5% higher, giving it a market valuation of $2.859 trillion. 

It rose as much as 2% during the session and the company was briefly worth $2.903 trillion. Apple closed 0.3% lower, giving the company a market capitalization of $2.886 trillion. 

"It was inevitable that Microsoft would overtake Apple since Microsoft is growing faster and has more to benefit from the generative AI revolution," D.A. Davidson analyst Gil Luria said at the time, according to Reuters.

The two tech titans have jostled for top spot over the years and Microsoft was ahead at last check, with a market cap of $3.085 trillion, compared with Apple's value of $2.684 trillion.

Analysts noted that Apple had been dealing with weakening demand, including for the iPhone, the company’s main source of revenue. 

Demand in China, a major market, has slumped as the country's economy makes a slow recovery from the pandemic and competition from Huawei.

Sales in China of Apple's iPhone fell by 24% in the first six weeks of 2024 compared with a year earlier, according to research firm Counterpoint, as the company contended with stiff competition from a resurgent Huawei "while getting squeezed in the middle on aggressive pricing from the likes of OPPO, vivo and Xiaomi," said senior Analyst Mengmeng Zhang.

“Although the iPhone 15 is a great device, it has no significant upgrades from the previous version, so consumers feel fine holding on to the older-generation iPhones for now," he said.

A man scrolling through Netflix on an Apple iPad Pro. Photo by Phil Barker/Future Publishing via Getty Images.

Future Publishing/Getty Images

Big plans for China

Counterpoint said that the first six weeks of 2023 saw abnormally high numbers with significant unit sales being deferred from December 2022 due to production issues.

Apple is planning to open its eighth store in Shanghai – and its 47th across China – on March 21.

Related: Tech News Now: OpenAI says Musk contract 'never existed', Xiaomi's EV, and more

The company also plans to expand its research centre in Shanghai to support all of its product lines and open a new lab in southern tech hub Shenzhen later this year, according to the South China Morning Post.

Meanwhile, over in Europe, Apple announced changes to comply with the European Union's Digital Markets Act (DMA), which went into effect last week, Reuters reported on March 12.

Beginning this spring, software developers operating in Europe will be able to distribute apps to EU customers directly from their own websites instead of through the App Store.

"To reflect the DMA’s changes, users in the EU can install apps from alternative app marketplaces in iOS 17.4 and later," Apple said on its website, referring to the software platform that runs iPhones and iPads. 

"Users will be able to download an alternative marketplace app from the marketplace developer’s website," the company said.

Apple has also said it will appeal a $2 billion EU antitrust fine for thwarting competition from Spotify  (SPOT)  and other music streaming rivals via restrictions on the App Store.

The company's shares have suffered amid all this upheaval, but some analysts still see good things in Apple's future.

Bank of America Securities confirmed its positive stance on Apple, maintaining a buy rating with a steady price target of $225, according to Investing.com

The firm's analysis highlighted Apple's pricing strategy evolution since the introduction of the first iPhone in 2007, with initial prices set at $499 for the 4GB model and $599 for the 8GB model.

BofA said that Apple has consistently launched new iPhone models, including the Pro/Pro Max versions, to target the premium market. 

Analyst says Apple selloff 'overdone'

Concurrently, prices for previous models are typically reduced by about $100 with each new release. 

This strategy, coupled with installment plans from Apple and carriers, has contributed to the iPhone's installed base reaching a record 1.2 billion in 2023, the firm said.

More Tech Stocks:

Apple has effectively shifted its sales mix toward higher-value units despite experiencing slower unit sales, BofA said.

This trend is expected to persist and could help mitigate potential unit sales weaknesses, particularly in China. 

BofA also noted Apple's dominance in the high-end market, maintaining a market share of over 90% in the $1,000 and above price band for the past three years.

The firm also cited the anticipation of a multi-year iPhone cycle propelled by next-generation AI technology, robust services growth, and the potential for margin expansion.

On Monday, Evercore ISI analysts said they believed that the sell-off in the iPhone maker’s shares may be “overdone.”

The firm said that investors' growing preference for AI-focused stocks like Nvidia  (NVDA)  has led to a reallocation of funds away from Apple. 

In addition, Evercore said concerns over weakening demand in China, where Apple may be losing market share in the smartphone segment, have affected investor sentiment.

And then ongoing regulatory issues continue to have an impact on investor confidence in the world's second-biggest company.

“We think the sell-off is rather overdone, while we suspect there is strong valuation support at current levels to down 10%, there are three distinct drivers that could unlock upside on the stock from here – a) Cap allocation, b) AI inferencing, and c) Risk-off/defensive shift," the firm said in a research note.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

International

Major typhoid fever surveillance study in sub-Saharan Africa indicates need for the introduction of typhoid conjugate vaccines in endemic countries

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high…

Published

on

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

Credit: IVI

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

 

The findings from this 4-year study, the Severe Typhoid in Africa (SETA) program, offers new typhoid fever burden estimates from six countries: Burkina Faso, Democratic Republic of the Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria, with four countries recording more than 100 cases for every 100,000 person-years of observation, which is considered a high burden. The highest incidence of typhoid was found in DRC with 315 cases per 100,000 people while children between 2-14 years of age were shown to be at highest risk across all 25 study sites.

 

There are an estimated 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths. However, with generic symptoms such as fever, fatigue, and abdominal pain, and the need for blood culture sampling to make a definitive diagnosis, it is difficult for governments to capture the true burden of typhoid in their countries.

 

“Our goal through SETA was to address these gaps in typhoid disease burden data,” said lead author Dr. Florian Marks, Deputy Director General of the International Vaccine Institute (IVI). “Our estimates indicate that introduction of TCV in endemic settings would go to lengths in protecting communities, especially school-aged children, against this potentially deadly—but preventable—disease.”

 

In addition to disease incidence, this study also showed that the emergence of antimicrobial resistance (AMR) in Salmonella Typhi, the bacteria that causes typhoid fever, has led to more reliance beyond the traditional first line of antibiotic treatment. If left untreated, severe cases of the disease can lead to intestinal perforation and even death. This suggests that prevention through vaccination may play a critical role in not only protecting against typhoid fever but reducing the spread of drug-resistant strains of the bacteria.

 

There are two TCVs prequalified by the World Health Organization (WHO) and available through Gavi, the Vaccine Alliance. In February 2024, IVI and SK bioscience announced that a third TCV, SKYTyphoid™, also achieved WHO PQ, paving the way for public procurement and increasing the global supply.

 

Alongside the SETA disease burden study, IVI has been working with colleagues in three African countries to show the real-world impact of TCV vaccination. These studies include a cluster-randomized trial in Agogo, Ghana and two effectiveness studies following mass vaccination in Kisantu, DRC and Imerintsiatosika, Madagascar.

 

Dr. Birkneh Tilahun Tadesse, Associate Director General at IVI and Head of the Real-World Evidence Department, explains, “Through these vaccine effectiveness studies, we aim to show the full public health value of TCV in settings that are directly impacted by a high burden of typhoid fever.” He adds, “Our final objective of course is to eliminate typhoid or to at least reduce the burden to low incidence levels, and that’s what we are attempting in Fiji with an island-wide vaccination campaign.”

 

As more countries in typhoid endemic countries, namely in sub-Saharan Africa and South Asia, consider TCV in national immunization programs, these data will help inform evidence-based policy decisions around typhoid prevention and control.

 

###

 

About the International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO) and developed a new-generation typhoid conjugate vaccine that is recently pre-qualified by WHO.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, a Country Office in Austria, and Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

CONTACT

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int


Read More

Continue Reading

International

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

Earlier today, CNBC’s…

Published

on

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever... And Debt Explodes

Earlier today, CNBC's Brian Sullivan took a horse dose of Red Pills when, about six months after our readers, he learned that the US is issuing $1 trillion in debt every 100 days, which prompted him to rage tweet, (or rageX, not sure what the proper term is here) the following:

We’ve added 60% to national debt since 2018. Germany - a country with major economic woes - added ‘just’ 32%.   

Maybe it will never matter.   Maybe MMT is real.   Maybe we just cancel or inflate it out. Maybe career real estate borrowers or career politicians aren’t the answer.

I have no idea.  Only time will tell.   But it’s going to be fascinating to watch it play out.

He is right: it will be fascinating, and the latest budget deficit data simply confirmed that the day of reckoning will come very soon, certainly sooner than the two years that One River's Eric Peters predicted this weekend for the coming "US debt sustainability crisis."

According to the US Treasury, in February, the US collected $271 billion in various tax receipts, and spent $567 billion, more than double what it collected.

The two charts below show the divergence in US tax receipts which have flatlined (on a trailing 6M basis) since the covid pandemic in 2020 (with occasional stimmy-driven surges)...

... and spending which is about 50% higher compared to where it was in 2020.

The end result is that in February, the budget deficit rose to $296.3 billion, up 12.9% from a year prior, and the second highest February deficit on record.

And the punchline: on a cumulative basis, the budget deficit in fiscal 2024 which began on October 1, 2023 is now $828 billion, the second largest cumulative deficit through February on record, surpassed only by the peak covid year of 2021.

But wait there's more: because in a world where the US is spending more than twice what it is collecting, the endgame is clear: debt collapse, and while it won't be tomorrow, or the week after, it is coming... and it's also why the US is now selling $1 trillion in debt every 100 days just to keep operating (and absorbing all those millions of illegal immigrants who will keep voting democrat to preserve the socialist system of the US, so beloved by the Soros clan).

And it gets even worse, because we are now in the ponzi finance stage of the Minsky cycle, with total interest on the debt annualizing well above $1 trillion, and rising every day

... having already surpassed total US defense spending and soon to surpass total health spending and, finally all social security spending, the largest spending category of all, which means that US debt will now rise exponentially higher until the inevitable moment when the US dollar loses its reserve status and it all comes crashing down.

We conclude with another observation by CNBC's Brian Sullivan, who quotes an email by a DC strategist...

.. which lays out the proposed Biden budget as follows:

The budget deficit will growth another $16 TRILLION over next 10 years. Thats *with* the proposed massive tax hikes.

Without them the deficit will grow $19 trillion.

That's why you will hear the "deficit is being reduced by $3 trillion" over the decade.

No family budget or business could exist with this kind of math.

Of course, in the long run, neither can the US... and since neither party will ever cut the spending which everyone by now is so addicted to, the best anyone can do is start planning for the endgame.

Tyler Durden Tue, 03/12/2024 - 18:40

Read More

Continue Reading

Trending